Globus Medical announces first surgeries using Excelsius3D

USA – Globus Medical, a musculoskeletal solutions company has announced the first surgeries using the Excelsius3D, an intelligent, intraoperative 3-in-1 imaging platform that is the latest addition to Globus Medical’s ExcelsiusTM Ecosystem of enabling technologies.

Excelsius3D received FDA 510(k) marketing clearance in 2021.

The imaging system is a mobile X-ray system that is designed for 2D fluoroscopy, 2D digital radiography and 3D imaging of adult and pediatric patients.

Excelsius3D features precise motion, omnidirectional wheels and intelligent maneuverability, according to Globus Medical. It has a compact footprint and eliminates a separate viewing station.

Globus Medical said it is ramping up production of the imaging system and will commercially launch in the fourth quarter.


Excelsius3D, in conjunction with the ExcelsiusGPS robotic navigation system, offers an intraoperative, image-guided robotic navigation solution that is intended to improve implant placement accuracy, reduce radiation exposure, and shorten operative times.

The system is indicated for use where a physician benefits from 2D and 3D information on anatomic structures and high contrast objects with high x-ray attenuation such as bony anatomy and metallic objects.

Excelsius3D images are compatible with image guided systems such as ExcelsiusGPS.

Meanwhile, Orchid Orthopedic Solutions, a leader in the manufacture of orthopedic implants and instruments, and GE Additive have signed a definitive agreement to continue driving the adoption of additive manufacturing to their suite of technologies through the development of electron beam melting (EBM) solutions in the medical implants sector.

Orchid will invest significantly in GE Additive EBM Spectra L systems, service agreements, AP&C metal powders, and AddWorks consultancy services to enable scalability and full production support for its customers.

In 2022, the first machines will be installed. Following machine installation and validation, Orchid anticipates being ready for production in 2024 to meet the needs of its customers.

GE Additive and Orchid are collaborating on joint marketing activities to raise awareness of EBM technology in 3D metal printed large joint orthopedic implants.

Orchid’s fleet of Spectra L machines, once installed and operational, will enable it to manufacture large orthopedic implants, such as complete knee components and acetabular cups, more competitively.

As the complexity of devices increases, this new EBM additive manufacturing capability with scalable precision enables cost-effective manufacturing to supplement traditional methods.

The Arcam EBM Spectra L enables mass production of parts by allowing parts to be tightly stacked without sacrificing quality.

Because of the improved melt process, material properties for thin and bulky geometries are consistent.

Key features include:

  • Improved part quality, including improved surface finish and material properties.
  • Reduced cost per part as a result of faster build speed, the largest EBM build volume, and the ability to tightly stack parts
  • Integrated system architecture with standardized IoT interface, data analytics for machine health monitoring, and the new PRS 30 Powder Recovery Station.

Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.